GABAPENTIN | A075428 | SANDOZ INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Suitability Petition Amendment from Rising Pharma Holdings, Inc. FDA-2026-P-5123 · 6 docket documents Rising Pharma Holdings, Inc. filed this amendment to suitability petition FDA-2026-P-5123 on June 4, 2026, in response to an FDA information request dated May 28, 2026, regarding Gabapentin Capsules, 150 mg, for which the company initially sought permission to file an ANDA. The company provided the | Suitability | 2026-06-05 | Open | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.